Table 1.

Registries and case reports focused on patients affected by fulminant myocarditis supported by IMPELLA devices published between 2010 and 2020.

Registries focused on FM cases supported by IMPELLA devices
Authors	Years	Patients, n.	Mean age, y.	Type of IMPELLA	Mean t on support, h.	Complications	Survival to hospital discharge
Annamalai et al. 2018	01/2009-02/2016	34 EMB in 11 cases	41	2.5 (41%) CP (35%) 5.0 (24%) - Concomitant RP (5%) - Concomitant va-ECMO (6%)	90.5±74.2	- Anemia requiring transfusion (20%) - Hemolysis (12%) - Device malfunction (15%) - Vascular complications (12%)	21 (62%)
Charalambous et al. 2018	01/2013-01/2016	6 Clinical diagnosis in all cases	43	NS	NS	NS	83.3%

Case reports focused on FM cases supported by IMPELLA devices
Authors	Type of use	Age, y.	Type of IMPELLA	Diagnosis / Histology	Outcome
Hasegawa-Tamba et al. 2019	Sole assist device	16	2.5	Eosinophilic myocarditis	Survived
Yamamoto et al. 2019	ECMELLA	26	2.5 followed by 5.0	Lymphocytic myocarditis	Survived
Ogawa et al. 2019	Sole assist device	39	5.0	Lymphocytic myocarditis	Survived
Pappalardo et al. 2018	BIPELLA	37	CP and RP	CMRI based diagnosis EMB inconclusive	Survived
Garg et al. 2017	Sole assist device	50	NS	GCM	HTx
Fox et al. 2017	Sole assist device	49	CP	Lymphocytic myocarditis	Survived
Burns et al. 2015	Sole assist device	48	5.0	Clinical diagnosis of viral myocarditis	Survived
Narain et al. 2012	ECMELLA	31	2.5	Viral myocarditis	Survived
Chaparro et al. 2012	ECMELLA	31	2.5	Lymphocytic myocarditis	Survived
Beurtheret et al. 2012	ECMELLA	34	5.0	Eosinophilic myocarditis	Died
Suradi et al. 2011	Sole assist device	44	2.5	GCM	LVAD
Khouzam et al. 2011	Sole assist device	36	2.5	Clinical diagnosis H1N1 positive	Died
Andrade et al. 2010	Sole assist device	13	5.0	Biopsy-proven viral myocarditis	Survived